{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:16:06Z","timestamp":1783044966674,"version":"3.54.6"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"crossref","award":["2021A1515110197"],"award-info":[{"award-number":["2021A1515110197"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Project supported by the KRT Plan of Guangdong Medical Development Foundation","award":["No.K-20240123"],"award-info":[{"award-number":["No.K-20240123"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82003799"],"award-info":[{"award-number":["82003799"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The National Key Research and Development Program of China","award":["2022YFC2705100\uff0c2022YFC2705101"],"award-info":[{"award-number":["2022YFC2705100\uff0c2022YFC2705101"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"DOI":"10.1007\/s10875-026-02027-9","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T09:57:01Z","timestamp":1778320621000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tofacitinib as a Successful Treatment for Hyper-IgE Syndrome and Autoimmunity Associated with Constitutive Activation of JAK3"],"prefix":"10.1007","volume":"46","author":[{"given":"Yuxin","family":"Pei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyila","family":"Abasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heying","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,9]]},"reference":[{"key":"2027_CR1","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1016\/j.cell.2022.09.023","volume":"185","author":"RL Philips","year":"2022","unstructured":"Philips RL, et al. The JAK-STAT pathway at 30: much learned, much more to do. Cell. 2022;185:3857\u201376.","journal-title":"Cell"},{"key":"2027_CR2","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.3390\/ijms25052977","volume":"25","author":"C Liongue","year":"2024","unstructured":"Liongue C, Ratnayake T, Basheer F, Ward AC. Janus kinase 3 (JAK3): a critical conserved node in immunity disrupted in immune cell cancer and immunodeficiency. Int J Mol Sci. 2024;25:2977.","journal-title":"Int J Mol Sci"},{"key":"2027_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2020-142078","volume":"136","author":"H Lesmana","year":"2020","unstructured":"Lesmana H, et al. Germline Gain-of-Function JAK3 Mutation in Familial Chronic Lymphoproliferative Disorder of NK Cells. Blood. 2020;136:9\u201310.","journal-title":"Blood"},{"key":"2027_CR4","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1182\/blood-2008-06-164368","volume":"113","author":"MG Cornejo","year":"2009","unstructured":"Cornejo MG, et al. Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation models. Blood. 2009;113:2746\u201354.","journal-title":"Blood"},{"key":"2027_CR5","doi-asserted-by":"publisher","first-page":"831279","DOI":"10.3389\/fimmu.2022.831279","volume":"13","author":"KL Smith","year":"2022","unstructured":"Smith KL, et al. Inborn errors of immunity associated with type 2 inflammation in the USIDNET registry. Front Immunol. 2022;13:831279.","journal-title":"Front Immunol"},{"key":"2027_CR6","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.3390\/life14101329","volume":"14","author":"F Galletta","year":"2024","unstructured":"Galletta F, et al. Pathophysiology of congenital high production of IgE and its consequences: a narrative review uncovering a neglected setting of disorders. Life. 2024;14:1329.","journal-title":"Life"},{"key":"2027_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/antib12040070","volume":"12","author":"P Kostova","year":"2023","unstructured":"Kostova P et al. Elevated IgE levels\u2014an allergy or an underlying inborn error of immunity in children with recurrent infections? Antibodies. 2023;12:70.","journal-title":"Antibodies"},{"key":"2027_CR8","doi-asserted-by":"publisher","first-page":"1516068","DOI":"10.3389\/fimmu.2025.1516068","volume":"16","author":"R AlYafie","year":"2025","unstructured":"AlYafie R, Velayutham D, van Panhuys N, Jithesh PV. The genetics of hyper IgE syndromes. Front Immunol. 2025;16:1516068.","journal-title":"Front Immunol"},{"key":"2027_CR9","doi-asserted-by":"publisher","first-page":"1057679","DOI":"10.3389\/fimmu.2022.1057679","volume":"13","author":"R Yaakoubi","year":"2023","unstructured":"Yaakoubi R, et al. Diagnostic challenge in a series of eleven patients with hyper IgE syndromes. Front Immunol. 2023;13:1057679.","journal-title":"Front Immunol"},{"key":"2027_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/intimm\/dxn134","volume":"21","author":"Y Minegishi","year":"2009","unstructured":"Minegishi Y, Karasuyama H. Defects in jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency. Int Immunol. 2009;21:105\u201312.","journal-title":"Int Immunol"},{"key":"2027_CR11","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s10875-024-01699-5","volume":"44","author":"C Tsilifis","year":"2024","unstructured":"Tsilifis C, et al. Omenn Syndrome in Two Infants with Different Hypomorphic Variants in Janus Kinase 3. J Clin Immunol. 2024;44:98.","journal-title":"J Clin Immunol"},{"key":"2027_CR12","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1146\/annurev.physiol.010908.163200","volume":"71","author":"Q Hamid","year":"2009","unstructured":"Hamid Q, Tulic M. Immunobiology of asthma. Annu Rev Physiol. 2009;71:489\u2013507.","journal-title":"Annu Rev Physiol"},{"key":"2027_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.biopha.2006.09.013","volume":"61","author":"NP Jayasekera","year":"2007","unstructured":"Jayasekera NP, Toma TP, Williams A, Rajakulasingam K. Mechanisms of immunotherapy in allergic rhinitis. Biomed Pharmacother Biomedecine Pharmacother. 2007;61:29\u201333.","journal-title":"Biomed Pharmacother Biomedecine Pharmacother"},{"key":"2027_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jaci.2023.07.008","volume":"153","author":"TH Nguyen","year":"2024","unstructured":"Nguyen TH, et al. Frequency of HLA-DR+CD38hi T-cells identifies and quantifies T-cell activation in hemophagocytic lymphohistiocytosis, hyperinflammation, and immune regulatory disorders. J Allergy Clin Immunol. 2024;153:309\u201319.","journal-title":"J Allergy Clin Immunol"},{"key":"2027_CR15","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.3390\/cells9112470","volume":"9","author":"AG Papavassiliou","year":"2020","unstructured":"Papavassiliou AG, Musti AM. The multifaceted output of c-jun biological activity: focus at the junction of CD8 T cell activation and exhaustion. Cells. 2020;9:2470.","journal-title":"Cells"},{"key":"2027_CR16","doi-asserted-by":"publisher","first-page":"6458","DOI":"10.1038\/s41467-022-34145-4","volume":"13","author":"Y Ye","year":"2022","unstructured":"Ye Y, et al. Single-cell profiling reveals distinct adaptive immune hallmarks in MDA5\u2009+\u2009dermatomyositis with therapeutic implications. Nat Commun. 2022;13:6458.","journal-title":"Nat Commun"},{"key":"2027_CR17","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1007\/s10875-023-01483-x","volume":"43","author":"N Ott","year":"2023","unstructured":"Ott N, Faletti L, Heeg M, Andreani V, Grimbacher B. JAKs and STATs from a Clinical Perspective: Loss-of-Function Mutations, Gain-of-Function Mutations, and Their Multidimensional Consequences. J Clin Immunol. 2023;43:1326\u201359.","journal-title":"J Clin Immunol"},{"key":"2027_CR18","doi-asserted-by":"publisher","first-page":"29022","DOI":"10.1074\/jbc.M115.670224","volume":"290","author":"E Losdyck","year":"2015","unstructured":"Losdyck E, et al. Distinct Acute Lymphoblastic Leukemia (ALL)-associated Janus Kinase 3 (JAK3) Mutants Exhibit Different Cytokine-Receptor Requirements and JAK Inhibitor Specificities. J Biol Chem. 2015;290:29022\u201334.","journal-title":"J Biol Chem"},{"key":"2027_CR19","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1182\/blood-2014-04-566687","volume":"124","author":"S Degryse","year":"2014","unstructured":"Degryse S, et al. JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model. Blood. 2014;124:3092\u2013100.","journal-title":"Blood"},{"key":"2027_CR20","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s10875-022-01273-x","volume":"42","author":"PB Lobo","year":"2022","unstructured":"Lobo PB, et al. Ex vivo effect of JAK inhibition on JAK-STAT1 pathway hyperactivation in patients with dominant-negative STAT3 mutations. J Clin Immunol. 2022;42:1193\u2013204.","journal-title":"J Clin Immunol"},{"key":"2027_CR21","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1182\/blood.2021014654","volume":"139","author":"P Goncalves","year":"2022","unstructured":"Goncalves P, et al. Defects in mucosal immunity and nasopharyngeal dysbiosis in HSC-transplanted SCID patients with IL2RG\/JAK3 deficiency. Blood. 2022;139:2585\u2013600.","journal-title":"Blood"},{"key":"2027_CR22","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.jaci.2017.03.049","volume":"141","author":"JW Leiding","year":"2018","unstructured":"Leiding JW, et al. Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutations. J Allergy Clin Immunol. 2018;141:704\u2013e7175.","journal-title":"J Allergy Clin Immunol"},{"key":"2027_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jaci.2023.10.018","volume":"153","author":"M Fischer","year":"2024","unstructured":"Fischer M, Olbrich P, Hadjadj J, Aumann V, Bakhtiar S, Barlogis V, et al. JAK inhibitor treatment for inborn errors of JAK\/STAT signaling: an ESID\/EBMT-IEWP retrospective study. J Allergy Clin Immunol. 2024;153:275\u201386.","journal-title":"J Allergy Clin Immunol"},{"key":"2027_CR24","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.jaci.2024.11.032","volume":"155","author":"Catak","year":"2025","unstructured":"Catak, et al. Ruxolitinib treatment ameliorates clinical, immunologic, and transcriptomic aberrations in patients with STAT3 gain-of-function disease. J Allergy Clin Immunol. 2025;155:784\u201391.","journal-title":"J Allergy Clin Immunol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-026-02027-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-026-02027-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-026-02027-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:22:01Z","timestamp":1783041721000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-026-02027-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2027"],"URL":"https:\/\/doi.org\/10.1007\/s10875-026-02027-9","relation":{},"ISSN":["1573-2592"],"issn-type":[{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,9]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethical Committee for Clinical Research and Animcal Trials of the First Affiliated Hospital of Sun Yat-sen University[(2021)137].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors have obtained consent to publish from the patient and his parents to report individual data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"71"}}